BC

Birchview Capital Portfolio holdings

AUM $101M
This Quarter Return
+18.58%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$115M
AUM Growth
+$115M
Cap. Flow
-$6.39M
Cap. Flow %
-5.53%
Top 10 Hldgs %
66.83%
Holding
65
New
5
Increased
9
Reduced
7
Closed
4

Top Buys

1
ACAD icon
Acadia Pharmaceuticals
ACAD
$2.31M
2
EQT icon
EQT Corp
EQT
$1.27M
3
CSTL icon
Castle Biosciences
CSTL
$684K
4
ATEC icon
Alphatec Holdings
ATEC
$612K
5
KALV icon
KalVista Pharmaceuticals
KALV
$417K

Top Sells

1
SILK
Silk Road Medical, Inc. Common Stock
SILK
$4.27M
2
HROW icon
Harrow
HROW
$3.47M
3
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
$1.73M
4
NBIX icon
Neurocrine Biosciences
NBIX
$1.38M
5
ELUT icon
Elutia
ELUT
$878K

Sector Composition

1 Healthcare 97.17%
2 Energy 2.83%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BLUE
51
DELISTED
bluebird bio
BLUE
$110K 0.1%
211,200
-100,000
-32% -$52K
ALMS
52
Alumis Inc. Common Stock
ALMS
$479M
$107K 0.09%
+10,000
New +$107K
LQDA icon
53
Liquidia Corp
LQDA
$2.38B
$100K 0.09%
10,000
– –
QURE icon
54
uniQure
QURE
$896M
$98.6K 0.09%
+20,000
New +$98.6K
IFRX icon
55
InflaRx
IFRX
$108M
$76.5K 0.07%
50,000
– –
TSVT
56
DELISTED
2seventy bio
TSVT
$74.7K 0.06%
15,833
-2,000
-11% -$9.44K
VTYX icon
57
Ventyx Biosciences
VTYX
$171M
$62.8K 0.05%
28,800
– –
ZNTL icon
58
Zentalis Pharmaceuticals
ZNTL
$122M
$58.9K 0.05%
16,000
– –
CABA icon
59
Cabaletta Bio
CABA
$133M
$47.2K 0.04%
10,000
– –
OM icon
60
Outset Medical
OM
$247M
$6.77K 0.01%
10,000
– –
CERO icon
61
CERo Therapeutics
CERO
$9.06M
$1.21K ﹤0.01%
12,972
– –
XOM icon
62
Exxon Mobil
XOM
$487B
– –
-5,849
Closed -$673K
GTHX
63
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-80,000
Closed -$182K
SILK
64
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
– –
-158,094
Closed -$4.27M
ETRN
65
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
– –
-133,050
Closed -$1.73M
1 2
3